CVS Health Reports Strong Q1 Performance

CVS Health Corporation has announced a notable 7% annual increase in its first-quarter revenue for the fiscal year 2025, reaching $94.6 billion. Despite this growth, the figures fell slightly below market expectations.

The company's net income for the quarter stood at $1.78 billion, a significant rise from the $1.12 billion reported in the same period in 2024. Diluted earnings per share (EPS) also saw an uptick, landing at $1.41 compared to $0.88 the previous year.

Revised Financial Outlook

CVS Health has adjusted its full-year 2025 cash flow from operations guidance downward by $500 million to $7.0 billion. Additionally, the GAAP diluted EPS guidance is now projected to be between $4.23 and $4.43.

Leadership's Perspective

"Our dedicated team has delivered positive results across all segments, reinforcing our commitment to enhancing health care for the 185 million consumers we serve," stated President and CEO David Joyner. Following the announcement, CVS's shares experienced a 4.79% increase in premarket trading, reaching $71.5 per share.